CIMAVAX-EGF

CIM to Launch CIMAvax on the International Market

After 25 long years of studies and innumerable clinical trials which took place in Canada, the United Kingdom, Malaysia, China…

6 years ago

BioCubaFarma Announces Joint Venture with Roswell Park Cancer Center

It was reported today in the Cuban media and by the BioCubaFarma Institute that the Roswell Park Comprehensive Cancer Center…

7 years ago

Cuba’s Top Three Innovations in Medical Research

Medical discoveries coming out of Cuba can claim to be some of the greatest innovations in medical research today. This…

9 years ago

Bioven to List Cuban Cancer Drug

CimaVax-EGF, the lung cancer vaccine developed by Cuba’s Center of Molecular Immunology is the very first therapeutic cancer vaccine.  It…

9 years ago

US to Test Cuban Lung Cancer Vaccine

CIMAVAX-EGF, an oncology vaccine, was developed in Cuba for the treatment of small cell lung cancer. Clinical trials have been…

9 years ago

The Pharmaceutical Industry in Cuba

Despite the economic consequences of over 50 years of the U.S. Embargo, Cuba has been able to create a strong…

10 years ago